{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T15:23:45Z","timestamp":1766676225366,"version":"3.40.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.virol.2023.07.006","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T22:50:46Z","timestamp":1690239046000},"page":"105-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Direct blue 53, a biological dye, inhibits SARS-CoV-2 infection by blocking ACE2 and spike interaction in vitro and in vivo"],"prefix":"10.1016","volume":"586","author":[{"given":"Yu","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-song","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0350-3020","authenticated-orcid":false,"given":"Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2023.07.006_bib1","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acsinfecdis.1c00070","article-title":"Small-molecule inhibitors of the coronavirus spike: ACE2 protein-protein interaction as blockers of viral attachment and entry for SARS-CoV-2","volume":"7","author":"Bojadzic","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.virol.2023.07.006_bib2","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.virol.2023.07.006_bib3","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s43440-022-00425-5","article-title":"Recent review of COVID-19 management: diagnosis, treatment and vaccination","volume":"74","author":"Chavda","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.virol.2023.07.006_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ph15091084","article-title":"Broad-spectrum small-molecule inhibitors of the SARS-CoV-2 spike-ACE2 protein-protein interaction from a chemical space of privileged protein binders","volume":"15","author":"Chuang","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.virol.2023.07.006_bib5","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1074\/jbc.AC120.013788","article-title":"Inhibition of SARS-CoV-2 by type I and type III interferons","volume":"295","author":"Felgenhauer","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2023.07.006_bib6","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2023.07.006_bib7","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 transmission and pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.virol.2023.07.006_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jneumeth.2005.08.006","article-title":"Fluorescence imaging of blood-brain barrier disruption","volume":"151","author":"Hawkins","year":"2006","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.virol.2023.07.006_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41594-020-0479-4","article-title":"Controlling the SARS-CoV-2 spike glycoprotein conformation","volume":"27","author":"Henderson","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2023.07.006_bib10","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/acs.jmedchem.7b00318","article-title":"The current state of peptide drug discovery: back to the future?","volume":"61","author":"Henninot","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virol.2023.07.006_bib11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s10646-019-02087-1","article-title":"Exposure to the azo dye Direct blue 15 produces toxic effects on microalgae, cladocerans, and zebrafish embryos","volume":"28","author":"Hernandez-Zamora","year":"2019","journal-title":"Ecotoxicology"},{"key":"10.1016\/j.virol.2023.07.006_bib12","article-title":"SARS-COV-2 variants: differences and potential of immune evasion","volume":"11","author":"Hirabara","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virol.2023.07.006_bib13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41586-020-2575-3","article-title":"Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2","volume":"585","author":"Hoffmann","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virol.2023.07.006_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2023.07.006_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.virol.2023.07.006_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104502","article-title":"From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses","volume":"85","author":"Kirtipal","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.virol.2023.07.006_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virol.2023.07.006_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virol.2023.07.006_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nprot.2016.174","article-title":"Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens","volume":"12","author":"Liu","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.virol.2023.07.006_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12250-020-00244-z","article-title":"Conditionally reprogrammed human normal airway epithelial cells at ALI: a physiological model for emerging viruses","volume":"35","author":"Liu","year":"2020","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virol.2023.07.006_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41421-021-00310-0","article-title":"Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells","volume":"7","author":"Ma","year":"2021","journal-title":"Cell discovery"},{"key":"10.1016\/j.virol.2023.07.006_bib22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMc2022236","article-title":"Remdesivir for the treatment of covid-19 - preliminary report","volume":"383","author":"McMahon","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2023.07.006_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virol.2023.07.006_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.crviro.2022.100019","article-title":"Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern","volume":"3","author":"Murer","year":"2022","journal-title":"Current research in virological science"},{"key":"10.1016\/j.virol.2023.07.006_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010832","article-title":"Thiopurines inhibit coronavirus Spike protein processing and incorporation into progeny virions","volume":"18","author":"Pringle","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2023.07.006_bib26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","article-title":"The evolution of commercial drug delivery technologies","volume":"5","author":"Vargason","year":"2021","journal-title":"Nature biomedical engineering"},{"key":"10.1016\/j.virol.2023.07.006_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.crmicr.2022.100158","article-title":"Methylene blue, Mycophenolic acid, Posaconazole, and Niclosamide inhibit SARS-CoV-2 Omicron variant BA.1 infection of human airway epithelial organoids","volume":"3","author":"Volle","year":"2022","journal-title":"Current research in microbial sciences"},{"key":"10.1016\/j.virol.2023.07.006_bib28","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virol.2023.07.006_bib29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41594-020-0478-5","article-title":"A thermostable, closed SARS-CoV-2 spike protein trimer","volume":"27","author":"Xiong","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2023.07.006_bib30","first-page":"62","article-title":"Does methylene blue satisfy an option in COVID-19 ARDS","volume":"22","author":"Yella","year":"2022","journal-title":"Infect. Disord.: Drug Targets"},{"key":"10.1016\/j.virol.2023.07.006_bib31","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2023.07.006_bib32","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","article-title":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003","volume":"362","author":"Zhong","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2023.07.006_bib33","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3389\/fimmu.2020.01061","article-title":"Interferon-alpha2b treatment for COVID-19","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223001459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223001459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T01:30:17Z","timestamp":1725931817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682223001459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":33,"alternative-id":["S0042682223001459"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2023.07.006","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct blue 53, a biological dye, inhibits SARS-CoV-2 infection by blocking ACE2 and spike interaction in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2023.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}